ArticleJournal of bone oncology2019

Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients.

Andy Göbel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.